University of Texas Health Science Center at Houston, Houston, TX, USA.
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211027100. doi: 10.1177/21501327211027100.
Understanding the mental health impact of the COVID-19 pandemic on persons receiving COVID-19 testing will help guide mental health interventions. We aimed to determine the association between sociodemographic factors and mental health symptoms at 8 weeks (baseline) after a COVID-19 test, and compare prevalence of mental health symptoms at baseline to those at 16-week follow-up.
Prospective cohort study of adults who received outpatient COVID-19 testing at primary care clinics. Logistic regression analyses were used to assess the association between sociodemographic characteristics and COVID-19 test results with mental health symptoms. Mental health symptoms reported at baseline were compared to symptoms at 16 weeks follow-up using conditional logistic regression analyses.
At baseline, a total of 124 (47.51%) participants reported at least mild depressive symptoms, 110 (42.15%) participants endorsed at least mild anxiety symptoms, and 94 participants (35.21%) endorsed hazardous use of alcohol. Females compared to males were at increased risk of at least mild depressive symptoms at baseline (Adjusted Odds Ratio (AOR): 2.08; 95% CI: 1.14-3.79). The odds of at least mild depressive symptoms was significantly lower among those residing in zip codes within the highest quartile compared to lowest quartile of household income (AOR: 0.37; 95% CI: 0.17-0.81). Also, non-Hispanic Whites had significantly higher odds of reporting hazardous alcohol use compared to non-Whites at baseline (AOR: 1.94; 95% CI: 1.05-3.57). The prevalence of mental health symptoms remained elevated after 16 weeks.
We found a high burden of symptoms of depression and anxiety as well as hazardous alcohol use in a diverse population who received testing for COVID-19 in the primary care setting. Primary care providers need to remain vigilant in screening for symptoms of mental health disorders in patients tested for COVID-19 well after initial testing.
了解 COVID-19 大流行对接受 COVID-19 检测人群的心理健康影响，有助于指导心理健康干预措施。我们旨在确定社会人口统计学因素与 COVID-19 检测后 8 周（基线）心理健康症状之间的关联，并比较基线时和 16 周随访时心理健康症状的患病率。
对在初级保健诊所接受门诊 COVID-19 检测的成年人进行前瞻性队列研究。采用逻辑回归分析评估社会人口统计学特征与 COVID-19 检测结果与心理健康症状之间的关系。使用条件逻辑回归分析比较基线时和 16 周随访时报告的心理健康症状。
基线时，共有 124 名（47.51%）参与者报告至少有轻度抑郁症状，110 名（42.15%）参与者报告至少有轻度焦虑症状，94 名（35.21%）参与者报告有危险饮酒行为。与男性相比，女性在基线时至少有轻度抑郁症状的风险增加（调整后优势比（AOR）：2.08；95%可信区间（CI）：1.14-3.79）。与收入最低四分位数相比，收入最高四分位数的邮政编码居住者至少有轻度抑郁症状的可能性显著降低（AOR：0.37；95% CI：0.17-0.81）。此外，与非白人相比，非西班牙裔白人在基线时报告危险饮酒的可能性显著更高（AOR：1.94；95% CI：1.05-3.57）。16 周后，心理健康症状的患病率仍然较高。
我们发现，在接受初级保健环境中 COVID-19 检测的多样化人群中，抑郁和焦虑症状以及危险饮酒行为的负担很高。初级保健提供者需要在 COVID-19 检测后很长时间内保持警惕，筛查接受 COVID-19 检测患者的心理健康障碍症状。
